anti-glycoprotein CAR-T cell therapy（Zhongshan Hospital Of Traditional Chinese Medicine）

N/A

Report date: 2022/07/20 13:22:56

Base Information

Drug Nameanti-glycoprotein CAR-T cell therapy（Zhongshan Hospital Of Traditional Chinese Medicine）

Drug Alias Nameanti-glycoprotein CAR-T cell

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionGlycoproteins inhibitors

TargetsGlycoproteins

Therapy Area/IndicationsNasopharyngeal Carcinoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesZhongshan Hospital Of Traditional Chinese Medicine

China Registration ClassN/A

Develop Information

Active CompaniesZhongshan Hospital Of Traditional Chinese Medicine

Inactive CompaniesN/A

Active IndicationsNasopharyngeal Carcinoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A